FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024884300> ?p ?o ?g. }

• W2024884300 endingPage "123" @default.
• W2024884300 startingPage "107" @default.
• W2024884300 abstract "1. 4-[2((1R,2R)-2-Hydroxycyclohexylamino)-benzothiazol-6-yloxyl]-pyridine-2-carboxylic acid methylamide (BLZ945) is a small molecule inhibitor of CSF-1R kinase activity within osteoclasts designed to prevent skeletal related events in metastatic disease. Key metabolites were enzymatically and structurally characterized to understand the metabolic fate of BLZ945 and pharmacological implications. The relative intrinsic clearances for metabolites were derived from in vitro studies using human hepatocytes, microsomes and phenotyped with recombinant P450 enzymes.2. Formation of a pharmacologically active metabolite (M9) was observed in human hepatocytes. The M9 metabolite is a structural isomer (diastereomer) of BLZ945 and is about 4-fold less potent. This isomer was enzymatically formed via P450 oxidation of the BLZ945 hydroxyl group, followed by aldo–keto reduction to the alcohol (M9).3. Two reaction phenotyping approaches based on fractional clearances were applied to BLZ945 using hepatocytes and liver microsomes. The fraction metabolized (fm) or contribution ratio was determined for each metabolic reaction type (oxidation, glucuronidation or isomerization) as well as for each metabolite. The results quantitatively illustrate contribution ratios of the involved enzymes and pathways, e.g. the isomerization to metabolite M9 accounted for 24% intrinsic clearance in human hepatocytes. In summary, contribution ratios for the Phase I and Phase II pathways can be determined in hepatocytes." @default.
• W2024884300 created "2016-06-24" @default.
• W2024884300 creator A5006891741 @default.
• W2024884300 creator A5009448621 @default.
• W2024884300 creator A5032833513 @default.
• W2024884300 creator A5033659864 @default.
• W2024884300 creator A5037887776 @default.
• W2024884300 creator A5055402965 @default.
• W2024884300 creator A5057363726 @default.
• W2024884300 creator A5058540463 @default.
• W2024884300 creator A5072749779 @default.
• W2024884300 creator A5072885531 @default.
• W2024884300 creator A5088909506 @default.
• W2024884300 date "2014-09-02" @default.
• W2024884300 modified "2023-10-01" @default.
• W2024884300 title "Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite" @default.
• W2024884300 cites W1497221593 @default.
• W2024884300 cites W1980485314 @default.
• W2024884300 cites W1996555078 @default.
• W2024884300 cites W2004171024 @default.
• W2024884300 cites W2008618763 @default.
• W2024884300 cites W2022327379 @default.
• W2024884300 cites W2033850902 @default.
• W2024884300 cites W2052260115 @default.
• W2024884300 cites W2078372543 @default.
• W2024884300 cites W2098898636 @default.
• W2024884300 cites W2104965603 @default.
• W2024884300 cites W2107535614 @default.
• W2024884300 cites W2126332858 @default.
• W2024884300 cites W2132852298 @default.
• W2024884300 cites W2134324150 @default.
• W2024884300 cites W2135319921 @default.
• W2024884300 cites W2138310781 @default.
• W2024884300 cites W2138873293 @default.
• W2024884300 cites W2139030573 @default.
• W2024884300 cites W2152964734 @default.
• W2024884300 cites W2161261761 @default.
• W2024884300 cites W4252543042 @default.
• W2024884300 doi "https://doi.org/10.3109/00498254.2014.945988" @default.
• W2024884300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25180976" @default.
• W2024884300 hasPublicationYear "2014" @default.
• W2024884300 type Work @default.
• W2024884300 sameAs 2024884300 @default.
• W2024884300 citedByCount "22" @default.
• W2024884300 countsByYear W20248843002016 @default.
• W2024884300 countsByYear W20248843002017 @default.
• W2024884300 countsByYear W20248843002018 @default.
• W2024884300 countsByYear W20248843002019 @default.
• W2024884300 countsByYear W20248843002020 @default.
• W2024884300 countsByYear W20248843002021 @default.
• W2024884300 countsByYear W20248843002022 @default.
• W2024884300 countsByYear W20248843002023 @default.
• W2024884300 crossrefType "journal-article" @default.
• W2024884300 hasAuthorship W2024884300A5006891741 @default.
• W2024884300 hasAuthorship W2024884300A5009448621 @default.
• W2024884300 hasAuthorship W2024884300A5032833513 @default.
• W2024884300 hasAuthorship W2024884300A5033659864 @default.
• W2024884300 hasAuthorship W2024884300A5037887776 @default.
• W2024884300 hasAuthorship W2024884300A5055402965 @default.
• W2024884300 hasAuthorship W2024884300A5057363726 @default.
• W2024884300 hasAuthorship W2024884300A5058540463 @default.
• W2024884300 hasAuthorship W2024884300A5072749779 @default.
• W2024884300 hasAuthorship W2024884300A5072885531 @default.
• W2024884300 hasAuthorship W2024884300A5088909506 @default.
• W2024884300 hasConcept C119795356 @default.
• W2024884300 hasConcept C126661725 @default.
• W2024884300 hasConcept C161790260 @default.
• W2024884300 hasConcept C181199279 @default.
• W2024884300 hasConcept C184235292 @default.
• W2024884300 hasConcept C185592680 @default.
• W2024884300 hasConcept C192989942 @default.
• W2024884300 hasConcept C2777477808 @default.
• W2024884300 hasConcept C2779907587 @default.
• W2024884300 hasConcept C55493867 @default.
• W2024884300 hasConcept C71240020 @default.
• W2024884300 hasConcept C87644729 @default.
• W2024884300 hasConceptScore W2024884300C119795356 @default.
• W2024884300 hasConceptScore W2024884300C126661725 @default.
• W2024884300 hasConceptScore W2024884300C161790260 @default.
• W2024884300 hasConceptScore W2024884300C181199279 @default.
• W2024884300 hasConceptScore W2024884300C184235292 @default.
• W2024884300 hasConceptScore W2024884300C185592680 @default.
• W2024884300 hasConceptScore W2024884300C192989942 @default.
• W2024884300 hasConceptScore W2024884300C2777477808 @default.
• W2024884300 hasConceptScore W2024884300C2779907587 @default.
• W2024884300 hasConceptScore W2024884300C55493867 @default.
• W2024884300 hasConceptScore W2024884300C71240020 @default.
• W2024884300 hasConceptScore W2024884300C87644729 @default.
• W2024884300 hasIssue "2" @default.
• W2024884300 hasLocation W20248843001 @default.
• W2024884300 hasLocation W20248843002 @default.
• W2024884300 hasOpenAccess W2024884300 @default.
• W2024884300 hasPrimaryLocation W20248843001 @default.
• W2024884300 hasRelatedWork W1959677388 @default.
• W2024884300 hasRelatedWork W1965614386 @default.
• W2024884300 hasRelatedWork W2009067244 @default.
• W2024884300 hasRelatedWork W2050115426 @default.
• W2024884300 hasRelatedWork W2067602209 @default.

• next